Literature DB >> 23643983

Identifying Ki-67 specific miRNA-mRNA interactions in malignant astrocytomas.

Yanwei Liu1, Kai Tang, Wei Yan, Yongzhi Wang, Gan You, Chunsheng Kang, Tao Jiang, Wei Zhang.   

Abstract

BACKGROUND: Ki-67 is an excellent indicator of glioma cell growth. However, limited information is available regarding the mechanisms underlying abnormal expression of Ki-67 in glioma tissue. The aim of this study is to identify Ki-67 specific miRNA-mRNA interactions on basis of miRNA and mRNA expression profilings.
METHODS: We performed a large-scale miRNA (n=829) and mRNA (n=29,421) expression profiling in primary glioblastoma multiforme (pGBM) and anaplastic astrocytoma (AA) tissues (with an aim to investigate Ki-67 related miRNAs and mRNAs). From target prediction databases, the targeting relationships between Ki-67 specific miRNAs and mRNAs were established, and functions of these mRNAs were analyzed by DAVID. The functional verifications of the candidate miRNA were also performed in LN229 cell line.
RESULTS: High expression level of Ki-67 protein predicted a shorter survival time for patients with AA. Integrated analysis of profiling data from pGBM and AA revealed 4 Ki-67 positively and 5 negatively correlated miRNAs, along with the top 12 Ki-67 positively and 2 negatively correlated mRNAs. By means of target prediction, we found that the target mRNAs employed by miR-218 were the most significant among Ki-67 specific mRNAs. Up-regulation of miR-218 was further demonstrated to reduce Ki-67 expression, promote apoptosis, and induce G0/G1 phase cell cycle arrest in LN229 cells.
CONCLUSIONS: Ki-67 protein may be regulated by specific miRNA-mRNA interactions which may contribute to the proliferation of glioma cells.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23643983     DOI: 10.1016/j.neulet.2013.04.030

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

1.  microRNA-182 inhibits the proliferation and migration of glioma cells through the induction of neuritin expression.

Authors:  Y A Feng; T E Liu; Yuncheng Wu
Journal:  Oncol Lett       Date:  2015-06-11       Impact factor: 2.967

2.  Radiomic features predict Ki-67 expression level and survival in lower grade gliomas.

Authors:  Yiming Li; Zenghui Qian; Kaibin Xu; Kai Wang; Xing Fan; Shaowu Li; Xing Liu; Yinyan Wang; Tao Jiang
Journal:  J Neurooncol       Date:  2017-09-12       Impact factor: 4.130

3.  Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms.

Authors:  Maria Braoudaki; George I Lambrou; Krinio Giannikou; Vasilis Milionis; Kalliopi Stefanaki; Diane K Birks; Neophytos Prodromou; Aggeliki Kolialexi; Antonis Kattamis; Chara A Spiliopoulou; Fotini Tzortzatou-Stathopoulou; Emmanouel Kanavakis
Journal:  J Hematol Oncol       Date:  2014-12-31       Impact factor: 17.388

4.  MiR-519d and miR-328-3p Combinatorially Suppress Breast Cancer Progression.

Authors:  Haiming Ma; Tao Liu; Yanhua Xu; Xinying Wang; Jin Wang; Xiaokang Liu
Journal:  Onco Targets Ther       Date:  2020-12-18       Impact factor: 4.147

5.  ATRX mRNA expression combined with IDH1/2 mutational status and Ki-67 expression refines the molecular classification of astrocytic tumors: evidence from the whole transcriptome sequencing of 169 samples samples.

Authors:  Jinquan Cai; Pei Yang; Chuanbao Zhang; Wei Zhang; Yanwei Liu; Zhaoshi Bao; Xing Liu; Wenzhong Du; Hongjun Wang; Tao Jiang; Chuanlu Jiang
Journal:  Oncotarget       Date:  2014-05-15

6.  IDH1/2 mutation status combined with Ki-67 labeling index defines distinct prognostic groups in glioma.

Authors:  Ailiang Zeng; Qi Hu; Yanwei Liu; Zheng Wang; Xiaoming Cui; Rui Li; Wei Yan; Yongping You
Journal:  Oncotarget       Date:  2015-10-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.